StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Operating Income by Quarter

Operating Income ($M)

QuarterlyAnnual

Novartis Operating Income: $1,843M in Q3 2026, down 59.1% from a year earlier.

Latest, Q3 2026
1,843
Period ended Sep 30, 2026
Change on a year earlier
-59.1%
4,501 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Operating income | 1 843 | 4 501”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating Income ($M)Year on yearSource
Q3 2026Sep 30, 20261,843-59.1%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20264,750-2.3%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20264,235-9.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20253,616+2.4%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20254,501+24.1%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20254,864+21.2%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20254,663+38.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20243,530+36.7%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,627+105.8%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20244,014+43.0%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20243,373+28.8%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20232,582+47.1%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20231,762-3.5%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20232,807+26.0%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2023Mar 31, 20232,618-8.2%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20221,755-31.5%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Operating Income ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-opinc

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.